Review



beadarray specific methods for illumina methylation and expression microarrays  (Illumina Inc)


Bioz Verified Symbol Illumina Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Illumina Inc beadarray specific methods for illumina methylation and expression microarrays
    Beadarray Specific Methods For Illumina Methylation And Expression Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/beadarray+specific+method+for+illumina+methylation+and+expression+microarrays/pmc11127974__42003_2024_6325_MOESM2_ESM-255-13-10
    Average 90 stars, based on 1 article reviews
    beadarray specific methods for illumina methylation and expression microarrays - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Gene Expression:

    Article Title: Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Article Snippet: .. Modulation of Global Gene Expression Profile in Pancreatic Carcinoma Cells Treated by Atorvastatin Using Illumina Microarray Method Modulation of global gene expression profiles was analyzed using P02 murine pancreatic carcinoma cells treated with atorvastatin and the illumina microarray approach. ..

    Microarray:

    Article Title: Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
    Article Snippet: .. Modulation of Global Gene Expression Profile in Pancreatic Carcinoma Cells Treated by Atorvastatin Using Illumina Microarray Method Modulation of global gene expression profiles was analyzed using P02 murine pancreatic carcinoma cells treated with atorvastatin and the illumina microarray approach. ..



    Similar Products

    90
    Illumina Inc beadarray specific methods for illumina methylation and expression microarrays
    Beadarray Specific Methods For Illumina Methylation And Expression Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/beadarray+specific+method+for+illumina+methylation+and+expression+microarrays/pmc11127974__42003_2024_6325_MOESM2_ESM-255-13-10
    Average 90 stars, based on 1 article reviews
    beadarray specific methods for illumina methylation and expression microarrays - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc exome chip genotyping method illumina humancoreexome-24 version 1-0a microarray
    Exome Chip Genotyping Method Illumina Humancoreexome 24 Version 1 0a Microarray, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/exome+chip+genotyping+method+illumina+humancoreexome+24+version+1+0a+microarray/pm30772277-59-11-15
    Average 90 stars, based on 1 article reviews
    exome chip genotyping method illumina humancoreexome-24 version 1-0a microarray - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc dna microarray hybridization method using illumina's beadchips
    Dna Microarray Hybridization Method Using Illumina's Beadchips, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/dna+microarray+hybridization+method+using+illumina+s+beadchips/pmc06042003-130-34-33
    Average 90 stars, based on 1 article reviews
    dna microarray hybridization method using illumina's beadchips - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc beadarray specific method for illumina methylation and expression microarrays
    Beadarray Specific Method For Illumina Methylation And Expression Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/beadarray+specific+method+for+illumina+methylation+and+expression+microarrays/pm26970123-555-7-4
    Average 90 stars, based on 1 article reviews
    beadarray specific method for illumina methylation and expression microarrays - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc variance-stabilizing transformation (vst) method designed for illumina microarray data
    Variance Stabilizing Transformation (Vst) Method Designed For Illumina Microarray Data, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/variance+stabilizing+transformation++vst+/10__1039_slash_c4mb00711e-41-13-12
    Average 90 stars, based on 1 article reviews
    variance-stabilizing transformation (vst) method designed for illumina microarray data - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc dna microarray method illumina ratref-12 v1
    Profiling the gene expression alterations following minocycline i.p. administration to CCI - exposed rats. Gene expression changes 7 days after nerve injury and administration of minocycline (30 mg/kg; i.p .; 16 h and 1 h before CCI and then for 7 days twice daily). The statistical analysis was performed at an ANOVA threshold value of p < 0.001 (N vs . V-CCI vs . MC-CCI). The results of the cDNA <t>microarray</t> analysis are presented in the form of a heat map. The individual columns represent the respective microarrays, while the individual rows represent the regulated genes. The intensity of the color reflects the relative abundance of the transcript and is proportional to the standard deviation from the in-row average, as indicated in the legend below the heat map. (A) The gene pattern represents changes in the abundance levels of 54 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; these abundance levels of these genes were not affected by the addition of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (B) Gene pattern B represents changes in the abundance levels of 39 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; the abundance levels of these genes were modulated by repeated intraperitoneal administration of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (C) The percentage analysis of the alterations in the CCI-induced gene expression profile in the spinal cord.
    Dna Microarray Method Illumina Ratref 12 V1, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/ratref+12+expression+beadchip/pmc04131481-47-1-4
    Average 90 stars, based on 1 article reviews
    dna microarray method illumina ratref-12 v1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc illumina microarray method
    Profiling the gene expression alterations following minocycline i.p. administration to CCI - exposed rats. Gene expression changes 7 days after nerve injury and administration of minocycline (30 mg/kg; i.p .; 16 h and 1 h before CCI and then for 7 days twice daily). The statistical analysis was performed at an ANOVA threshold value of p < 0.001 (N vs . V-CCI vs . MC-CCI). The results of the cDNA <t>microarray</t> analysis are presented in the form of a heat map. The individual columns represent the respective microarrays, while the individual rows represent the regulated genes. The intensity of the color reflects the relative abundance of the transcript and is proportional to the standard deviation from the in-row average, as indicated in the legend below the heat map. (A) The gene pattern represents changes in the abundance levels of 54 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; these abundance levels of these genes were not affected by the addition of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (B) Gene pattern B represents changes in the abundance levels of 39 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; the abundance levels of these genes were modulated by repeated intraperitoneal administration of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (C) The percentage analysis of the alterations in the CCI-induced gene expression profile in the spinal cord.
    Illumina Microarray Method, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/illumina+microarray+method/pm22549877-154-14-14
    Average 90 stars, based on 1 article reviews
    illumina microarray method - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc epigenome-wide screening method based on illumina 27k dna methylation microarray
    Profiling the gene expression alterations following minocycline i.p. administration to CCI - exposed rats. Gene expression changes 7 days after nerve injury and administration of minocycline (30 mg/kg; i.p .; 16 h and 1 h before CCI and then for 7 days twice daily). The statistical analysis was performed at an ANOVA threshold value of p < 0.001 (N vs . V-CCI vs . MC-CCI). The results of the cDNA <t>microarray</t> analysis are presented in the form of a heat map. The individual columns represent the respective microarrays, while the individual rows represent the regulated genes. The intensity of the color reflects the relative abundance of the transcript and is proportional to the standard deviation from the in-row average, as indicated in the legend below the heat map. (A) The gene pattern represents changes in the abundance levels of 54 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; these abundance levels of these genes were not affected by the addition of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (B) Gene pattern B represents changes in the abundance levels of 39 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; the abundance levels of these genes were modulated by repeated intraperitoneal administration of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (C) The percentage analysis of the alterations in the CCI-induced gene expression profile in the spinal cord.
    Epigenome Wide Screening Method Based On Illumina 27k Dna Methylation Microarray, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/illumina+microarray+method/epigenome+wide+screening+method+based+on+illumina+27k+dna+methylation+microarray/10__2147_slash_ott__s51041-27-37-42
    Average 90 stars, based on 1 article reviews
    epigenome-wide screening method based on illumina 27k dna methylation microarray - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Profiling the gene expression alterations following minocycline i.p. administration to CCI - exposed rats. Gene expression changes 7 days after nerve injury and administration of minocycline (30 mg/kg; i.p .; 16 h and 1 h before CCI and then for 7 days twice daily). The statistical analysis was performed at an ANOVA threshold value of p < 0.001 (N vs . V-CCI vs . MC-CCI). The results of the cDNA microarray analysis are presented in the form of a heat map. The individual columns represent the respective microarrays, while the individual rows represent the regulated genes. The intensity of the color reflects the relative abundance of the transcript and is proportional to the standard deviation from the in-row average, as indicated in the legend below the heat map. (A) The gene pattern represents changes in the abundance levels of 54 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; these abundance levels of these genes were not affected by the addition of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (B) Gene pattern B represents changes in the abundance levels of 39 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; the abundance levels of these genes were modulated by repeated intraperitoneal administration of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (C) The percentage analysis of the alterations in the CCI-induced gene expression profile in the spinal cord.

    Journal: Molecular Pain

    Article Title: Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain

    doi: 10.1186/1744-8069-10-47

    Figure Lengend Snippet: Profiling the gene expression alterations following minocycline i.p. administration to CCI - exposed rats. Gene expression changes 7 days after nerve injury and administration of minocycline (30 mg/kg; i.p .; 16 h and 1 h before CCI and then for 7 days twice daily). The statistical analysis was performed at an ANOVA threshold value of p < 0.001 (N vs . V-CCI vs . MC-CCI). The results of the cDNA microarray analysis are presented in the form of a heat map. The individual columns represent the respective microarrays, while the individual rows represent the regulated genes. The intensity of the color reflects the relative abundance of the transcript and is proportional to the standard deviation from the in-row average, as indicated in the legend below the heat map. (A) The gene pattern represents changes in the abundance levels of 54 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; these abundance levels of these genes were not affected by the addition of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (B) Gene pattern B represents changes in the abundance levels of 39 mRNA transcripts induced in the lumbar spinal segment on day 7 of neuropathic pain; the abundance levels of these genes were modulated by repeated intraperitoneal administration of minocycline (30 mg/kg; 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days). (C) The percentage analysis of the alterations in the CCI-induced gene expression profile in the spinal cord.

    Article Snippet: The DNA microarray method (Illumina RatRef-12 V1) was used to analyze the changes in mRNA levels in the lumbar segment of the spinal cord.

    Techniques: Gene Expression, Microarray, Standard Deviation

    Genes from the B1 transcription pattern - similarly spinally and DRG regulated by minocycline. Comparison of the CCI-induced changes in transcript levels of genes with expression pattern B1 ( Cd40 , Clec7a and Apobec3b ) in the lumbar spinal cord using microarray (A, D, G) and qPCR (B, E, H) analysis; transcript levels in the DRG (C, F, I) and the modulation by repeated intraperitoneal administration of minocycline (30 mg/kg; i.p. 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days) were also examined. The statistical analysis was performed using an ANOVA and Bonferroni’s test. **p < 0.01 and ***p < 0.001 indicate a significant difference when compared to the control (naïve rats); # p < 0.05, ## p < 0.01 and ### p < 0.001 indicate a significant difference when compared to the V-CCI rats. Naive (N), vehicle (V; water for injection), minocycline (MC).

    Journal: Molecular Pain

    Article Title: Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain

    doi: 10.1186/1744-8069-10-47

    Figure Lengend Snippet: Genes from the B1 transcription pattern - similarly spinally and DRG regulated by minocycline. Comparison of the CCI-induced changes in transcript levels of genes with expression pattern B1 ( Cd40 , Clec7a and Apobec3b ) in the lumbar spinal cord using microarray (A, D, G) and qPCR (B, E, H) analysis; transcript levels in the DRG (C, F, I) and the modulation by repeated intraperitoneal administration of minocycline (30 mg/kg; i.p. 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days) were also examined. The statistical analysis was performed using an ANOVA and Bonferroni’s test. **p < 0.01 and ***p < 0.001 indicate a significant difference when compared to the control (naïve rats); # p < 0.05, ## p < 0.01 and ### p < 0.001 indicate a significant difference when compared to the V-CCI rats. Naive (N), vehicle (V; water for injection), minocycline (MC).

    Article Snippet: The DNA microarray method (Illumina RatRef-12 V1) was used to analyze the changes in mRNA levels in the lumbar segment of the spinal cord.

    Techniques: Comparison, Expressing, Microarray, Control, Injection

    Genes from the B1 transcription pattern - differentially spinally and DRG regulated by minocycline. Comparison of the changes in the transcripts levels of genes with expression pattern B1 ( Slc7a7 and Fam22f ) in the lumbar spinal cord using microarray (A, D) and qPCR (B, E) analysis; transcript levels in the DRG (C, F) under neuropathic pain and the modulation by repeated intraperitoneal administration of minocycline (30 mg/kg; i.p. 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days) were also examined using qPCR analysis. The statistical analysis was performed using an ANOVA and Bonferroni’s test. ***p < 0.001 indicates a significant difference when compared to the control (naïve rats); # p < 0.05, ## p < 0.01 and ### p < 0.001 indicate a significant difference when compared to the V-CCI rats. Naive (N), vehicle (V; water for injection), minocycline (MC).

    Journal: Molecular Pain

    Article Title: Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain

    doi: 10.1186/1744-8069-10-47

    Figure Lengend Snippet: Genes from the B1 transcription pattern - differentially spinally and DRG regulated by minocycline. Comparison of the changes in the transcripts levels of genes with expression pattern B1 ( Slc7a7 and Fam22f ) in the lumbar spinal cord using microarray (A, D) and qPCR (B, E) analysis; transcript levels in the DRG (C, F) under neuropathic pain and the modulation by repeated intraperitoneal administration of minocycline (30 mg/kg; i.p. 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days) were also examined using qPCR analysis. The statistical analysis was performed using an ANOVA and Bonferroni’s test. ***p < 0.001 indicates a significant difference when compared to the control (naïve rats); # p < 0.05, ## p < 0.01 and ### p < 0.001 indicate a significant difference when compared to the V-CCI rats. Naive (N), vehicle (V; water for injection), minocycline (MC).

    Article Snippet: The DNA microarray method (Illumina RatRef-12 V1) was used to analyze the changes in mRNA levels in the lumbar segment of the spinal cord.

    Techniques: Comparison, Expressing, Microarray, Control, Injection

    Genes from the B2 transcription pattern - similarly spinally and DRG regulated by minocycline. Comparison of the changes in the transcript levels of genes with expression pattern B2 ( Rwdd3 and Gimap5 ) in the lumbar spinal cord using microarray (A, D) and qPCR (B, E) analysis; transcript levels in the DRG (C, F) under neuropathic pain and the modulation by repeated intraperitoneal administration of minocycline (30 mg/kg; i.p. 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days) were also examined using qPCR. The statistical analysis was performed using an ANOVA and Bonferroni’s test. **p <0.01 and ***p <0.001 indicate a significant difference when compared to the control (naïve rats); # p < 0.05, ## p < 0.01 and ### p < 0.001 indicate a significant difference when compared to the V-CCI rats. Naive (N), vehicle (V; water for injection), minocycline (MC).

    Journal: Molecular Pain

    Article Title: Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain

    doi: 10.1186/1744-8069-10-47

    Figure Lengend Snippet: Genes from the B2 transcription pattern - similarly spinally and DRG regulated by minocycline. Comparison of the changes in the transcript levels of genes with expression pattern B2 ( Rwdd3 and Gimap5 ) in the lumbar spinal cord using microarray (A, D) and qPCR (B, E) analysis; transcript levels in the DRG (C, F) under neuropathic pain and the modulation by repeated intraperitoneal administration of minocycline (30 mg/kg; i.p. 16 h and 1 h before sciatic nerve damage and then twice daily for 7 days) were also examined using qPCR. The statistical analysis was performed using an ANOVA and Bonferroni’s test. **p <0.01 and ***p <0.001 indicate a significant difference when compared to the control (naïve rats); # p < 0.05, ## p < 0.01 and ### p < 0.001 indicate a significant difference when compared to the V-CCI rats. Naive (N), vehicle (V; water for injection), minocycline (MC).

    Article Snippet: The DNA microarray method (Illumina RatRef-12 V1) was used to analyze the changes in mRNA levels in the lumbar segment of the spinal cord.

    Techniques: Comparison, Expressing, Microarray, Control, Injection